Skip to content

9 % B. Braun

DRUG20 trials

Sponsors

Exo Biologics, Universitair Ziekenhuis Gent, St Antonius Hospital, Assistance Publique Hopitaux De Paris, St. Olavs Hospital HF

Conditions

Alzheimer DiseaseAortic stenosisBronchopulmonary DysplasiaCluster headacheDiffuse Cutaneous Systemic Sclerosis (dcSSc)GastroscopyHemodynamic stable term and preterm neonates requiring semi-elective endotracheal intubation.Idiopathic Pulmonary Fibrosis (IPF)

Phase 1

Phase 2

Analgesic effect of intravenous lidocaïne and its mechanisms in patients suffering from chronic inflammatory bowel disease (IBD) with abdominal pain.
RecruitingCTIS2023-508224-35-01
CHU De LiegeInflammatory Bowel disease
Start: 2024-09-30Target: 80Updated: 2025-03-21
Therapeutic evaluation of low-dose IL-2-based immunomodulatory approach in patients with early AD
Not yet recruitingCTIS2024-516565-36-00
Groupe Hospitalier Universitaire Paris Psychiatrie Et NeuroscienceAlzheimer Disease
Target: 45Updated: 2025-06-13
Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, immunogenicity and safety of one dose of OVX836 influenza vaccine 480μg, after intramuscular administration in healthy subjects aged 18-59 years
Active, not recruitingCTIS2024-520354-37-00
OsivaxInfluenza disease
Start: 2025-09-08Target: 2850Updated: 2025-11-19
A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
RecruitingCTIS2025-521278-32-00
Mediar Therapeutics Inc.Idiopathic Pulmonary Fibrosis (IPF)
Start: 2025-12-04Target: 58Updated: 2025-11-26
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study of NAV-240 in Adult Participants with Moderate-to-Severe Hidradenitis Suppurativa
Not yet recruitingCTIS2025-523557-33-00
Navigator Medicines Inc.Moderate-to-Severe Hidradenitis Suppurativa
Target: 80Updated: 2026-03-26
Pain Relief at Screening for Retinopathy of Prematurity - The PROPER study
Not yet recruitingCTIS2023-507975-23-01
St. Olavs Hospital HFRetinopathy of prematurity
Target: 33Updated: 2026-06-22
A Phase 2 Randomized, Double-blind, Placebo-Controlled Study to Assess the Safety and Efficacy of MTX-474 in the Treatment of Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Not yet recruitingCTIS2025-523288-39-00
Mediar Therapeutics Inc.Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Target: 3Updated: 2026-06-29

Phase 3

Remifentanil for endotracheal intubation in neonates: a dose-finding trial.
RecruitingCTIS2022-501858-11-00
Universitair Ziekenhuis GentHemodynamic stable term and preterm neonates requiring semi-elective endotracheal intubation.
Start: 2023-12-26Target: 50Updated: 2025-11-21
Routine versus selective protamine administration to reduce bleeding complications after transcatheter aortic valve implantation
CompletedCTIS2023-504205-36-00
St Antonius HospitalAortic stenosis
Start: 2023-11-01End: 2026-01-02Target: 800Updated: 2025-11-20
Preemptive Treament with acyclovir in intubated and mechanically ventilated patients with Herpes simplex virus oropharyngeal reactivation and one or less organ failure (PTH2)
RecruitingCTIS2023-505510-26-00
Assistance Publique Hopitaux De ParisPatients in ICU with invasive mechanical ventilation and HSV throat reactivation with 1 or no organ failures.
Start: 2024-06-19Target: 246Updated: 2026-01-07
(REGON) Repeated corticosteroid injections around the Greater Occipital Nerve (GON) as prophylactic treatment in chronic cluster headache
Not yet recruitingCTIS2024-514311-10-00
Leids Universitair Medisch Centrum (LUMC)Cluster headache
Target: 50Updated: 2024-11-26
TOCIACS : Efficacy and safety of Tocilizumab for acute chest syndrome treatment in paediatric and adult patients with sickle cell disease
RecruitingCTIS2023-505109-17-00
Assistance Publique Hopitaux De ParisSickle cell disease
Start: 2025-08-27Target: 130Updated: 2025-12-17
ZAMBA: Zoledronic Acid for Modic Back Pain. A randomized, double blind, placebo-controlled, multicenter trial
Not yet recruitingCTIS2024-517345-14-00
Oslo University Hospital HFLow Back Pain
Target: 118Updated: 2025-10-30

Phase 4

Effect of intravenous Lidocaine bolus on the median effective concentration (EC50) of Propofol during target controlled infusion (TCI : Schnider model) for gastroscopy in adult patients : a prospective, randomized, double-blinded study
Not yet recruitingCTIS2023-509888-24-00
Hopital ErasmeGastroscopy
Target: 50Updated: 2024-03-25
Perioperative oral analgesia versus intravenous analgesia for knee arthroscopy, a randomized, double-blinded, non-inferiority trial. OVIKA-trial - S68618
Active, not recruitingCTIS2024-510789-17-00
UZ LeuvenPostoperative pain relief after knee arthroscopy
Start: 2024-09-03Target: 108Updated: 2024-06-03
Selän alueen poikkeava aktiivisuus servikaalisessa dystoniassa
RecruitingCTIS2024-517068-43-00
Pirkanmaan hyvinvointialue, Pirkanmaan hyvinvointialuejossa poikkeavaa lihasaktiivisuutta esiintyy kaulan alueen lihaksissa aiheuttaen tyypillisiä virheasentoja kuten pään kiertymistä, jossa poikkeavaa lihasaktiivisuutta pyritään vähentämään lamaamalla kohdelihasten toimintaa, kallistumista ja vapinaa. Servikaalista dystoniaa hoidetaan ensisijaisesti paikallisesti botuliinitoksiinipistoksilla +1
Start: 2023-03-27Target: 150Updated: 2024-08-27
Does placement of a TAP block in patients undergoing laparoscopic inguinal hernia repair have a more efficacious analgesic effect than local infiltration at the surgical site: a randomized controlled trial.
RecruitingCTIS2024-515759-39-00
Universitair Ziekenhuis Brusselinguinal hernia
Start: 2025-05-13Target: 80Updated: 2025-10-30
Intubation Conditions in Morbidly Obese Patients with Rapid Sequence Induction: A Comparative Study of Rocuronium Dosing based on Ideal vs. Real Body Weight
WithdrawnCTIS2025-520977-37-00
UZ BrusselObesity
Target: 182Updated: 2025-11-12